Author Correction: Current Anesthesiology Reports (2021) 11(1):37–47
The original version of this article contained mistakes; corrections are numbered below:
1. The author affiliations should read as follows:
Thomas Drew1,2,3 and Jose C.A. Carvalho4
1 Department of Anaesthesia, The Rotunda Hospital, Dublin, Ireland
2 Department of Anaesthesia, Beaumont Hospital, Dublin, Ireland
3 Department of Anaesthesia, University College London Hospital, United Kingdom
4 Department of Anesthesiology and Pain Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Canada
2. Table 1, third column, second row, should read as follows:
Elective CD: 100 μg over ≥ 30 s Intrapartum CD: 100 μg over ≥ 30 s Smaller doses (as low as 20 μg) may be sufficient at elective CD; in this case, doses can be repeated if required, up to 100 μg
Do not exceed 100 μg
3. An “E)’ should be removed before the final heading:
Optimizing a Prevention Strategy—Balancing Safety and Efficacy. The Role of the 2019 Uterotonic Consensus Guidelines on the Use of Uterotonic Drugs During Cesarean Delivery
4. Fig.1 caption should be in keeping with the actual figure, with a capital A and B.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s40140-021-00444-7
Rights and permissions
About this article
Cite this article
Drew, T., Carvalho, J.C.A. Author Correction: Pharmacologic Prevention and Treatment of Postpartum Hemorrhage. Curr Anesthesiol Rep 11, 145 (2021). https://doi.org/10.1007/s40140-021-00449-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40140-021-00449-2